Astal Laboratories re-appoints V R P S & Co. as internal auditor

1 min read     Updated on 31 May 2026, 05:36 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Astal Laboratories Limited has re-appointed M/s V R P S & Co. Chartered Accountants as its internal auditor for FY 2026-27. The board approved the appointment on May 30, 2026, to comply with regulatory requirements. The firm is independent and unrelated to the company's directors or key management personnel.

powered bylight_fuzz_icon
41774774

*this image is generated using AI for illustrative purposes only.

Astal Laboratories Limited has re-appointed M/s V R P S & Co. Chartered Accountants as its internal auditor for the financial year 2026-27. The decision was taken by the Board of Directors at a meeting held on May 30, 2026, to ensure compliance with the Companies Act 2013 and SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

The re-appointment is effective from May 30, 2026. The firm, holding Firm Registration Number 006340S, was selected to provide a wide spectrum of services across sectors with a focus on result-oriented solutions. The auditor is committed to delivering value-added services with high standards of ethics, integrity, and quality.

Board Meeting Details

The board meeting to consider the re-appointment commenced at 05:00 P.M. and concluded at 07:20 P.M. on May 30, 2026. The disclosure was made to BSE Limited under Regulation 30 of the SEBI (LODR) Regulations, 2015, read with the SEBI Master Circular.

Key Appointment Details

The following table outlines the specific details of the re-appointment:

S. No. Particulars Details
1. Reason for Change Re-appointment to comply with the Companies Act 2013 and Listing Regulations
2. Date of Appointment 30/05/2026
3. Terms of Appointment Re-appointed as Internal Auditors for the Financial Year 2026-27
4. Brief Profile Single window professional outfit providing services across sectors
5. Disclosure of Relationships Not related to any Directors, Key Managerial Personnel, or their relatives

The company confirmed that M/s V R P S & Co. holds no relationship with any of the directors, key managerial personnel, or their relatives, ensuring independence in the audit process.

Historical Stock Returns for Astal Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+4.75%+12.57%-1.64%-1.32%-5.12%+784.70%

How will the re-appointment of the same auditor impact the company's internal control effectiveness over the next fiscal year?

What specific compliance challenges does Astal Laboratories anticipate under the Companies Act 2013 for FY 2026-27?

Will the auditor's focus on result-oriented solutions lead to any strategic shifts in the company's operational audits?

Astal Laboratories reports consolidated revenue surge in FY26

1 min read     Updated on 31 May 2026, 01:28 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Astal Laboratories Limited reported a substantial increase in consolidated revenue to ₹24,934.88 lakh for the financial year ended March 31, 2026, compared to ₹6,435.61 lakh in the prior year. The consolidated profit after tax rose to ₹1,470.94 lakh from ₹892.53 lakh. On a standalone basis, revenue from operations reached ₹15,599.53 lakh with a profit of ₹811.55 lakh. The board approved the audited financial results on May 30, 2026, and addressed a typographical error in a prior submission.

powered bylight_fuzz_icon
41265902

*this image is generated using AI for illustrative purposes only.

Astal Laboratories Limited has reported a significant surge in consolidated revenue for the financial year ended March 31, 2026, driven by its manufacturing and trading operations. The company's board, meeting on May 30, 2026, approved the audited standalone and consolidated financial results for Q4FY26 and FY26. The filing includes a resubmission due to a typographical error in the earlier submission, accompanied by an unmodified auditor's report from Sathuluri & Co., Chartered Accountants.

For the full fiscal year FY26, the company recorded a consolidated total revenue of ₹24,934.88 lakh, a sharp increase from ₹6,435.61 lakh in the previous year. Profit after tax for the year stood at ₹1,470.94 lakh, compared to ₹892.53 lakh in FY25. On a standalone basis, revenue from operations for FY26 was ₹15,599.53 lakh, while profit after tax was ₹811.55 lakh.

Financial Performance Summary

Metric FY26 (Consolidated) FY25 (Consolidated) Change
Total Revenue ₹24,934.88 lakh ₹6,435.61 lakh Increase
Profit After Tax ₹1,470.94 lakh ₹892.53 lakh Increase
Total Expenses ₹23,161.85 lakh ₹5,237.86 lakh Increase

The board also considered the appointment of an internal auditor for the financial year 2026-27. The trading window for designated persons and their immediate relatives, which had been closed since April 01, 2026, will reopen forty-eight hours after the conclusion of the board meeting. The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Astal Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+4.75%+12.57%-1.64%-1.32%-5.12%+784.70%

What strategic initiatives will Astal Laboratories pursue to sustain the nearly four-fold revenue growth into FY27?

How will the company utilize the increased profitability to fund future expansion or reduce debt?

What specific factors drove the disproportionate rise in total expenses alongside the revenue surge?

More News on Astal Laboratories

1 Year Returns:-5.12%